Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Finar? Find Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)- to address your drug delivery challenges on PharmaCompass.

Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, monosodium salt, (11beta)-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 7 USDMF, 7 CEP/COS, 1 JDMF, 3 EU WC, 2 NDC API, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

63 FDF Dossiers, 30 FDA Orange Book, 2 Europe, 4 Canada, 8 Australia, 1 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 100MG BASE/VIAL, INJECTABLE;INJECTION - EQ 1GM BASE/VIAL, INJECTABLE;INJECTION - EQ 250MG BASE/VIAL, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL

RELATED EXCIPIENT COMPANIES

1 Nanjing Well Pharmaceutical, 1 Actylis, 1 Finar

EXCIPIENTS BY APPLICATIONS

2 Topical, 1 Parenteral, 1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

12 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Exclusivities

1 US Exclusivities

REF. STANDARDS & IMPURITIES

2 JP

2 JP

$ Xls

Filters

Pregn-4-ene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-, Monosodium Salt, (11beta)-

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Finar

filter Capability Reset all filters

filter Country Reset all filters

01

Finar

Medlab Asia & Asia Health

Not Confirmed